Does AMISULPRIDE Cause Electrocardiogram qt prolonged? 167 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 167 reports of Electrocardiogram qt prolonged have been filed in association with AMISULPRIDE (Barhemsys). This represents 5.3% of all adverse event reports for AMISULPRIDE.
167
Reports of Electrocardiogram qt prolonged with AMISULPRIDE
5.3%
of all AMISULPRIDE reports
4
Deaths
84
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From AMISULPRIDE?
Of the 167 reports, 4 (2.4%) resulted in death, 84 (50.3%) required hospitalization, and 39 (23.4%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMISULPRIDE. However, 167 reports have been filed with the FAERS database.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Therapeutic product effect incomplete (200)
Off label use (191)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which AMISULPRIDE Alternatives Have Lower Electrocardiogram qt prolonged Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE